tiprankstipranks
Chiasma (CHMA)
NASDAQ:CHMA
US Market

Chiasma Stock Price & Analysis

0 Followers

CHMA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.77 - $5.74
Previous Close$3.76
VolumeN/A
Average Volume (3M)2.30M
Market Cap$237.81M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
P/E Ratio-2.4
Beta1.26
Next EarningsN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-1.59
Shares OutstandingN/A
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume1,207,163
30 Day Avg. Volume1,103,593
P/B RatioN/A
P/S RatioN/A
P/CF RatioN/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
AlphaN/A
Number of Analyst Covering0


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

CHMA FAQ

What was Chiasma’s price range in the past 12 months?
Chiasma lowest stock price was $2.77 and its highest was $5.74 in the past 12 months.
    What is Chiasma’s market cap?
    Chiasma’s market cap is $237.81M.
      When is Chiasma’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Chiasma’s earnings last quarter?
      Currently, no data Available
      Is Chiasma overvalued?
      According to Wall Street analysts Chiasma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Chiasma pay dividends?
        Chiasma does not currently pay dividends.
        What is Chiasma’s EPS estimate?
        Chiasma’s EPS estimate is -$1.59.
          How many shares outstanding does Chiasma have?
          Chiasma has 63,250,000 shares outstanding.
            What happened to Chiasma’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Chiasma?
            Among the largest hedge funds holding Chiasma’s share is Bruce & Co., Inc.. It holds Chiasma’s shares valued at 4M.

              ---

              Chiasma Stock Analysis

              Smart ScoreUnderperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              1
              The Chiasma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Chiasma

              Chiasma, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing and commercializing oral forms of therapies that are available by injection. Its products include octreotide capsules and clinical trials. The firm's Transient Permeability Enhancer (TPE) technology platform, seeks to develop oral medications. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Waltham, MA.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Aravive
              Pfizer
              Lexicon Pharmaceuticals
              Novartis
              Strongbridge Biopharma

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis